Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...

According to research presented at the EAHAD 2024 Annual Congress, miRNA signatures show promise as biomarkers for hemophilic ...

In the post-op SAKK 09/10 trial, only patients in the higher PORTOS score group benefited from radiation therapy dose escalation (clinical progression free survival HR 0.19, 95% CI 0.05-0.70; p = 0.01 ...